Gold Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Gold Investment Management's BMY Position: Q1 2026 in Review
Gold Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 12,542 shares worth $761K. The position accounts for 0.24% of the portfolio, ranked #83.
Gold Investment Management first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Gold Investment Management held 12,542 shares of Bristol-Myers Squibb worth $761K as of Q1 2026.
- Gold Investment Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.24% of Gold Investment Management's portfolio in Q1 2026, its #83 holding.
- Gold Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Gold Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.